Tag: Pharmaceutical industry
Bankruptcy trick is not an option for Bayer
Weed killer containing glyphosate There is still no quick solution in sight for Bayer in the compensation lawsuits in the USA. (Photo: Reuters) Dusseldorf It is still one of the…
Hype or Lifesaver? Artificial intelligence is set to revolutionize drug searches
Frankfurt After the IT industry, the pharmaceutical industry is now also increasing its investments in artificial intelligence (AI). This is shown by a number of takeovers and alliances completed in…
Dax group Merck is streamlining pharmaceutical research – jobs in the USA are being eliminated
Frankfurt The Darmstadt-based Merck Group is trimming its pharmaceutical research for greater efficiency and is now also making cuts in staff. At the US site in Billerica near Boston, 133…
Undercover biotech star expands into cell therapy
Frankfurt Novel cell and gene therapies have been causing a sensation in medicine for several years. German pharmaceutical companies do not yet play a major role here. But a biotech…
Undercover biotech star expands into cell therapy
Frankfurt Novel cell and gene therapies have been causing a sensation in medicine for several years. German pharmaceutical companies do not yet play a major role here. But a biotech…
12 answers to the question of what waves Corona will make in 2023
Berlin The pandemic phase of Corona is over, but Sars-Cov-2 remains present even in the endemic. Experts from various disciplines explain what this means in the coming months and where…
Moderna scores with vaccine against RS virus
Frankfurt The US biotech group Moderna has underpinned the performance of its mRNA technology with another positive study. Its vaccine candidate “mRNA-1345” against the respiratory syncytial virus (RSV) achieved a…
IPO still possible in 2023
Schott CEO Frank Heinricht Mainz When Schott boss Frank Heinricht reports on the past 2022 financial year at the headquarters of the Mainz-based glass specialist Schott this Wednesday morning, he…
Biotech companies will raise less capital in 2022
Frankfurt After record figures in the first two years of the corona pandemic, German biotech companies raised significantly less capital in 2022. A total of 921 million euros in fresh…
Stock market week winners and losers
Bayer factory The entry of two activist investors caused movement in the share. (Photo: dpa) Dusseldorf The German stock market also ended the second stock exchange week of the year…
New omicron subline should become dominant
After the above-average number of respiratory diseases a few weeks ago, people in Germany seem to be struggling less with it again. The estimated rate of acute respiratory diseases fell…
Investors are demanding a new CEO from outside
Werner Bauman The Bayer boss will vacate his post by April 2024 at the latest. (Photo: imago images/sepp spiegl) Dusseldorf, Frankfurt The entry of several activist investors into Bayer continues…
Biontech and Moderna in the expansion race
Frankfurt Your sales in the Covid business will fall significantly in the current year. In research, however, Moderna and Biontech are continuing to expand at high speed. This was made…
Investors are demanding a new CEO from outside
Werner Bauman The Bayer boss will vacate his post by April 2024 at the latest. (Photo: imago images/sepp spiegl) Dusseldorf, Frankfurt The entry of several activist investors into Bayer continues…
Activist funds target Bayer
Bayer Cross in Leverkusen: The group has halved its stock market value since the Monsanto takeover. (Photo: dpa) Dusseldorf In the new year, Bayer AG is increasingly being targeted by…
Mainz-based vaccine pioneer takes over British start-up Instadeep
Biontech founder Ugur Sahin The aim is to make Biontech a technology company in which AI is seamlessly integrated into the work. (Photo: imago images/photothek) Frankfurt With the largest acquisition…
Dax group Bayer is again showing confidence in the growth of its pharmaceutical division
Frankfurt Bayer believes its pharmaceuticals division will grow faster in the long term than previously assumed by many external observers. The Dax group has now almost doubled the sales forecast…
Dax group Bayer is again showing confidence in the growth of its pharmaceutical division
Frankfurt Bayer believes its pharmaceuticals division will grow faster in the long term than previously assumed by many external observers. The Dax group has now almost doubled the sales forecast…
Funds decide on measures against drug shortages
Berlin The statutory health insurance companies (GKV) have decided on measures to alleviate the strained supply of children’s medication. The so-called fixed amounts for certain drugs with the active ingredients…
New activist investor from the USA gets involved
Bayer plant in Wuppertal Bayer shares rose by almost four percent to 52.48 euros at the beginning of the week. (Photo: dpa) Dusseldorf Bayer AG has a new activist US…